Bisphosphonates and reduction of skeletal events in patients with bone metastatic breast cancer.
Rizzoli
René
R
D000284:Administration, Oral; D001859:Bone Neoplasms / Q000150:complications* / Q000556:secondary*; D001862:Bone Resorption; D001943:Breast Neoplasms / Q000473:pathology*; D002986:Clinical Trials as Topic; D004164:Diphosphonates / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D000077557:Ibandronic Acid; D007262:Infusions, Intravenous
D004164:Diphosphonates; D000077557:Ibandronic Acid